FDA weighs changes to policy on advisor conflicts

FDA may loosen its conflicts-of-interest rules governing scientists who serve on its advisory committees, Commissioner Margaret Hamburg said, in an attempt to ensure that it gets enough expert feedback on potential drug approvals and safety moves. Report

Suggested Articles

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.

ICER said that Vertex's triplet CF therapy Trikafta would only be cost effective if the price were dropped from $311,000 to no more than $85,500.